Pfizer Limited

NSEI:PFIZER Stock Report

Market Cap: ₹183.1b

Pfizer Future Growth

Future criteria checks 1/6

Pfizer is forecast to grow earnings and revenue by 14% and 6.9% per annum respectively while EPS is expected to grow by 13.9% per annum.

Key information

14.0%

Earnings growth rate

13.95%

EPS growth rate

Pharmaceuticals earnings growth18.5%
Revenue growth rate6.9%
Future return on equityn/a
Analyst coverage

Low

Last updated08 Sep 2026

Recent future growth updates

Recent updates

Analysis Article • Jul 14

There May Be Some Bright Spots In Pfizer's (NSE:PFIZER) Earnings

Soft earnings didn't appear to concern Pfizer Limited's ( NSE:PFIZER ) shareholders over the last week. We think that...
Analysis Article • Dec 30

Pfizer Limited's (NSE:PFIZER) Price Is Out Of Tune With Earnings

With a median price-to-earnings (or "P/E") ratio of close to 25x in India, you could be forgiven for feeling...
Analysis Article • Nov 25

Pfizer's (NSE:PFIZER) Solid Profits Have Weak Fundamentals

Pfizer Limited's ( NSE:PFIZER ) robust earnings report didn't manage to move the market for its stock. Our analysis...
Analysis Article • Sep 13

Pinning Down Pfizer Limited's (NSE:PFIZER) P/E Is Difficult Right Now

With a median price-to-earnings (or "P/E") ratio of close to 28x in India, you could be forgiven for feeling...
Analysis Article • May 28

Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 28%

The Pfizer Limited ( NSE:PFIZER ) share price has done very well over the last month, posting an excellent gain of 28...
Analysis Article • May 26

Pfizer (NSE:PFIZER) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Unsurprisingly, Pfizer Limited's ( NSE:PFIZER ) stock price was strong on the back of its healthy earnings report...
Analysis Article • Mar 03

Pfizer Limited's (NSE:PFIZER) Share Price Not Quite Adding Up

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 24x, you may consider Pfizer...
Analysis Article • Nov 28

Some Confidence Is Lacking In Pfizer Limited's (NSE:PFIZER) P/E

Pfizer Limited's ( NSE:PFIZER ) price-to-earnings (or "P/E") ratio of 39.3x might make it look like a sell right now...
Analysis Article • Aug 31

We Think Pfizer (NSE:PFIZER) Can Stay On Top Of Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Aug 07

Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 25%

Despite an already strong run, Pfizer Limited ( NSE:PFIZER ) shares have been powering on, with a gain of 25% in the...
Analysis Article • May 25

Weak Statutory Earnings May Not Tell The Whole Story For Pfizer (NSE:PFIZER)

Pfizer Limited's ( NSE:PFIZER ) recent weak earnings report didn't cause a big stock movement. Our analysis suggests...
Analysis Article • Feb 13

Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Jan 17

Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price

With a price-to-earnings (or "P/E") ratio of 37.4x Pfizer Limited ( NSE:PFIZER ) may be sending bearish signals at the...
Analysis Article • Mar 15

Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Earnings and Revenue Growth Forecasts

NSEI:PFIZER - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202828,9159,3647,325N/A4
3/31/202726,4978,0915,920N/A4
6/30/202625,6987,352N/AN/AN/A
3/31/202625,1977,2249,4239,676N/A
12/31/202524,8238,536N/AN/AN/A
9/30/202523,7538,3938,8049,098N/A
6/30/202523,2158,086N/AN/AN/A
3/31/202522,8147,6766,3166,598N/A
12/31/202422,3616,155N/AN/AN/A
9/30/202422,3816,1794,0144,165N/A
6/30/202422,2476,085N/AN/AN/A
3/31/202421,9325,5132,3792,568N/A
12/31/202322,1925,021N/AN/AN/A
9/30/202323,0105,2284,3225,040N/A
6/30/202323,6326,849N/AN/AN/A
3/31/202324,2486,2392,9073,557N/A
12/31/202224,0416,201N/AN/AN/A
9/30/202224,5836,1331,3411,493N/A
6/30/202224,5714,452N/AN/AN/A
3/31/202226,1106,1266,5186,671N/A
12/31/202125,9615,873N/AN/AN/A
9/30/202125,1375,8477,0187,147N/A
6/30/202124,7285,731N/AN/AN/A
3/31/202122,4044,9764,0964,273N/A
12/31/202022,0585,001N/AN/AN/A
9/30/202021,5054,9794,1294,004N/A
6/30/202021,2215,208N/AN/AN/A
3/31/202021,5175,091N/A3,232N/A
12/31/201921,8535,156N/AN/AN/A
9/30/201921,6095,085N/A1,716N/A
6/30/201921,1364,500N/AN/AN/A
3/31/201920,8154,291N/A978N/A
12/31/201820,6584,241N/AN/AN/A
9/30/201820,0853,794N/AN/AN/A
6/30/201820,5993,947N/AN/AN/A
3/31/201819,6853,601N/A3,318N/A
12/31/201718,8663,236N/AN/AN/A
9/30/201719,2152,987N/AN/AN/A
6/30/201718,8603,139N/AN/AN/A
3/31/201719,6633,368N/A3,288N/A
12/31/201620,4532,737N/AN/AN/A
9/30/201620,5952,711N/AN/AN/A
6/30/201620,3502,276N/AN/AN/A
3/31/201620,1233,050N/A3,455N/A
12/31/201519,6491,680N/AN/AN/A
9/30/201519,3341,460N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PFIZER's forecast earnings growth (14% per year) is above the savings rate (6.9%).

Earnings vs Market: PFIZER's earnings (14% per year) are forecast to grow slower than the Indian market (16.8% per year).

High Growth Earnings: PFIZER's earnings are forecast to grow, but not significantly.

Revenue vs Market: PFIZER's revenue (6.9% per year) is forecast to grow slower than the Indian market (11.3% per year).

High Growth Revenue: PFIZER's revenue (6.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PFIZER's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 05:32
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pfizer Limited is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit Bhat360 ONE Capital Market Private Limited
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited